Sahajanand Medical Technologies, India Receives CE mark on Two Sirolimus Eluting Coronary Stents. Digg this page for free send this page to a friend Add to your del.icio.us account

The CE approval for Supralimus速 and Supralimus-Core速 brings the company the distinction of being the first in the world to have CE approval for both Sirolimus and Paclitaxel -eluting coronary stents and in total three CE approved drug eluting stents.

The CE mark for Supralimus速 and Supralimus-Core速 is a significant accomplishment that
substantiates our products excellent clinical outcomes. This further confirms our commitment to
providing patients and clinicians new treatment options for coronary artery disease. shared Dhirajlal
Kotadia-CEO of Sahajanand, The excellent flexibility, highly deliverable system and proven safety and
efficacy of Sirolimus with the biodegradable polymers make our stents an excellent choice for a variety of patients he added.

The drug coating in multiple layers with the use of biodegradable layers for the Supralimus and
Supralimus Core stent is designed to deliver the drug in a biphasic manner: an initial burst dose,
followed by a controlled release of the drug which will likely reduce late adverse clinical events
compared to stents with non-biodegradable polymer said Dr. Atul Abhyankar, Medical Director of
SMT and a renowned cardiologist. In the early days of evolution of drug eluting stents SMT had the
foresight about the safety of biodegradable polymers and was the first to pioneer the utilization of
biodegradable polymer on all of its type of drug 'eluting stents ' he added.
Dr. Pedro Lemos MD, Ph.D, from InCor Institute, University of S達o Paulo Medical School shared his
own experience I have been using the Supralimus stent for more than 5 years now, with an accumulated
clinical experience that sums hundreds of patients. In addition, we have run a randomized trial that evaluated the short and long-term outcomes of patients treated with that stent. Both in daily practice as
well as in the context of a clinical study, the Supralimus presented a very good clinical performance.
SMT offers Stainless Steel and Cobalt Chromium bare metal stents, Paclitaxel eluting Stainless Steel stent
and Sirolimus eluting Stainless Steel and Cobalt Chromium stents. The wide range of sizes of both Supralimus速 and Supralimus'Core速 from 8 mm to 40 mm with one of lowest strut thickness of CE approved chromium-cobalt and stainless steel stents.

Indications (Supralimus)

Supralimus速 Sirolimus eluting coronary stent system is indicated for use in-patients with symptomatic ischemic heart disease due to coronary artery lesions with a reference vessel diameter ranging from 2.25 mm to 4.00 mm and is intended to improve coronary luminal diameter.

Indications (Supralimus-Core)

Supralimus-Core Sirolimus eluting coronary stent system is indicated for use in-patients with symptomatic ischemic heart
disease due to coronary artery lesions with a reference vessel diameter ranging from 2.5 mm to 3.5 mm and is intended to improve coronary luminal diameter.
User comments, Ratings and Reviews
News Reviews and Ratings
Be the first person to review this news article. By reviewing the news article you are automatically sent to our Online Sweepstakes and any questions on journal postings and more info from here
News Album Team,  Thursday, May 17, 2012 12:32:24 AM
Note: To write new journal then start here. The below is only to re-write the existing journal
Write your own Review on This News:

Required valid email. Confirmation sent here.
Not Much. 1 2 3 4 5 So Much......!

Human Verification Code     
[Bookmark & read later / Comment this story ]
Share this article:

You can Digg this article: Digg this page for free
Send Page to Friend(s):send this page to a friend
Bookmark with del.icio.us:Add to your del.icio.us account

Cast My Opinion

  

Article Taged as : sahajanand, medical, technologies,, india, receives, mark, sirolimus, eluting, coronary, stents., sahajanand, medical, technologies,, receives, sirolimus, eluting, coronary, stents., sahajanand, technologies, announced, sirolimus, supralimus皰,, supralimus-cor,

News Article Source & Groups

You can find this article under group. And brought to you by Channel ,
The XMl Feed Type and collected data bytes sized news and still counting.
Feed Server name is and Code Page (Not Defined/Un Known)

: : Sahajanand Medical Technologies, India Receives CE mark on Two Sirolimus Eluting Coronary Stents.
Date Listed : Wednesday, June 29, 2011
Source : ,

Related Stories
Home | Topics | Tell a Friend | Webmaster | Events | Subscribe | Link us | Submit News | My List